Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PPD and Evidera have joined the Massachusetts Institute of Technology Center for Biomedical Innovation’s New Drug Development Paradigms initiative as a strategic partner.
read more
Eurofins Scientific has signed an outsourcing agreement with Astellas to outsource one of its internal testing laboratories Astellas Analytical Science Laboratories.
read more
LabConnect has completed phase one of an 11,000+ square foot facility expansion in Johnson City, Tennessee.
read more
Aptinyx announced Allergan has exercised its option to acquire drug candidate AGN-241751, an oral small-molecule N-methyl-D-aspartate (NMDA) receptor modulator.
read more
Elligo Health Research has acquired ePatientFinder’s Clinical Trial Exchange technology platform and referring practice network.
read more
Oncternal Therapeutics announced a clinical supply arrangement with Pharmacyclics.
read more
Recipharm has established a dedicated taskforce to manage the potential impact of Brexit on its organization.
read more
Stellar Biotechnologies announced that third-party trial results have demonstrated that the company's KLH manufacturing methods achieve robust viral clearance.
read more
AGC Biologics will supply bulk drug substance for the launch of Portola Pharmaceuticals' Andexxa [coagulation factor Xa (recombinant), inactivated-zhzo].
read more
Bicycle Therapeutics announced it is expanding its collaboration with AstraZeneca to include additional targets in respiratory and cardio-metabolic diseases.
read more
Gary Tanner, a former executive at Valeant Pharmaceuticals, and Andrew Davenport, the former CEO of Philidor Rx Services, for engaging in a multimillion-dollar kickback scheme.
read more
Fujifilm has announced the extension of its gene therapy and viral vaccine Fill/Finish capabilities to provide services in support of late phase candidates and commercial supply.
read more
Tanner Pharma Group has announced the signing of a distribution agreement with Partner Therapeutics, (PTx), an integrated biopharmaceutical company.
read more
PerkinElmer has acquired Shanghai Spectrum Instruments.
read more
Samsung BioLogics announced today that a third monoclonal antibody Drug Substance has been licensed by the FDA for its second plant.
read more